Butantan Foundation
Butantan Foundation
Explore linked clinical trials.7 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Prospective Safety Cohort Study After VLA1553 Vaccination in Municipalities Selected for Participation in the VLA1553 Pilot Vaccination Strategy in Brazil | Alphavirus infectious disease, Infections, Mosquito-Borne Diseases, RNA Virus Infections, Togaviridae infectious disease, arbovirus infection, chikungunya, vector-borne disease, viral infectious disease | Active, not recruiting | Not stated | 2026-07-21 | NCT07254702 | |
| Phase 3b Trial To Evaluate Safety And Immune Response (Superiority) of a Two-Dose Butantan-DV Regimen And The Standard Single Dose In Dengue-Naive Children/Adolescents and Immune Response (Non-inferiority) in a Manufacturing Facility Change (DEN-06-IB) | Dengue Fever With Warning Signs | Not yet recruiting | Phase 3 | 2026-07-20 | NCT07712926 | |
| VLA1553-403 Pregnancy Surveillance Study | Alphavirus infectious disease, Infections, Mosquito-Borne Diseases, RNA Virus Infections, Togaviridae infectious disease, arbovirus infection, chikungunya, vector-borne disease, viral infectious disease | Enrolling by invitation | Not stated | 2026-07-20 | NCT07414524 | |
| Observational Study to Assess the Effectiveness of VLA1553 Vaccine in Preventing Chikungunya During a Pilot Vaccination Strategy in Brazil | Alphavirus infectious disease, Infections, Mosquito-Borne Diseases, RNA Virus Infections, Togaviridae infectious disease, arbovirus infection, chikungunya, vector-borne disease, viral infectious disease | Enrolling by invitation | Not stated | 2026-07-17 | NCT07347002 | |
| Butantan-DV Vaccine in Elderly Populations (DEN-04-IB) | Flaviviridae infectious disease, Flavivirus Infections, Infections, Mosquito-Borne Diseases, RNA Virus Infections, arbovirus infection, dengue disease, vector-borne disease, viral hemorrhagic fever, viral infectious disease | Recruiting | Phase 3 | 2026-07-16 | NCT06891950 | |
| Safety and Immunogenicity of the Monovalent Influenza Vaccine A (H5N8) (Inactivated, Fragmented and Adjuvanted) in Adults and Older Adults | Infections, RNA Virus Infections, avian influenza, bird disease, influenza, non-human animal disease, viral infectious disease | Recruiting | Phase 1 / Phase 2 | 2026-04-02 | NCT06842173 | |
| Assessment of Chikungunya Virus Seroprevalence Before VLA1553 Vaccination in the Municipalities Selected for Participation in the VLA1553 Pilot Vaccination Strategy in Brazil | Alphavirus infectious disease, Infections, Mosquito-Borne Diseases, RNA Virus Infections, Togaviridae infectious disease, arbovirus infection, chikungunya, vector-borne disease, viral infectious disease | Active, not recruiting | Not stated | 2026-02-11 | NCT07163845 |